FURIEX PHARMACEUTICALS INC - COM (FURX)

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM
Total 13F shares
6,858,066
Share change
+362,200
Total reported value
$728,037,586
Put/Call ratio
781%
Price per share
$106.18
Number of holders
100
Value change
+$103,092,138
Number of buys
55
Number of sells
73

Institutional Holders of FURIEX PHARMACEUTICALS INC - COM (FURX) as of Q2 2014

As of 30 Jun 2014, FURIEX PHARMACEUTICALS INC - COM (FURX) was held by 100 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,858,066 shares. The largest 10 holders included D. E. Shaw & Co., Inc., AQR CAPITAL MANAGEMENT LLC, Magnetar Financial LLC, MORGAN STANLEY, OXFORD ASSET MANAGEMENT, ARROWGRASS CAPITAL PARTNERS (US) LP, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, JPMORGAN CHASE & CO, and BlackRock Fund Advisors. This page lists 100 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.